News2020-04-02T15:24:00+11:00

Topics & Insight That Affect Our Members

308, 2021

IRSA ASM 2021 – Update

By |Categories: News|

The ASM scientific program sessions are being edited and will be available for all ASM delegates to view within the next two weeks.

1307, 2021

IRSA Gold Medal Recipient – Professor Tim Buckenham

By |Categories: News|

The IRSA Gold Medal is the highest accolade to be awarded by IRSA. This award acknowledges significant contribution to promotion, teaching, research, and overall advancement of the specialty of Interventional Radiology (IR) in Australia and New Zealand. Professor Buckenham was presented this most prestigious award at the IRSA ASM on 30 June 2021.

1207, 2021

Winner of the IRSA 2021 Abstract Prize

By |Categories: News|

IRSA are pleased to advise that winner of the IRSA 2021 Registrar Abstract Prize is Dr Nicholas Cheung for his submission of Stability of Doxorubicin in Radiocontrast Medium for Use in Conventional TACE Procedures.

2406, 2021

ET 2021 – European Conference on Embolotherapy

By |Categories: News|

Did you miss a satellite symposium at ET 2021 or want to revisit a topic of special interest to you? Remember that all industry content, including the seven comprehensive satellite symposia hosted by the most important players in the field, remain available free of charge via the congress platform!

2212, 2020

Hepatocellular Carcinoma (HCC) Consensus Statement

By |Categories: News|

The Australian recommendations for the management of hepatocellular carcinoma were developed by more than sixty expert clinicians with the principle aim of improving the standard of care provided to patients suffering with this condition in Australia. This online, unabridged version of the recommendations provides detailed background information including technical notes.

1007, 2020

Public Summary Document Application No. 1466 – Decision

By |Categories: News|

In 2016, IRSA applied to MSAC to restore public funding for a selected patient group likely to benefit from early vertebroplasty. The application was based on the VAPOUR trial. We are pleased to announce MSAC has supported the application for the patient subgroup in the VAPOUR trial who showed greatest benefit from vertebroplasty. The decision is published on the MSAC website as a Public Summary Document (PSD).

1805, 2020

Road Map for Advancing IR and INR in Australia and New Zealand

By |Categories: News|

In March 2019, the Interventional Radiology Committee released a white paper on Interventional Radiology for consultation to College members and other key stakeholders. The document was developed with the purpose of informing the College membership and stakeholder groups of the current and long-term positioning of IR and INR in Australia and New Zealand.

204, 2020

CIRSE-COVID-19 Resource Centre

By |Categories: News|

The CIRSE publications department have put together a range of useful links and resources for reference during the COVID-19 crisis.

2508, 2019

Consensus Guidelines on anticoagulants in IR

By |Categories: News|

IRSA would like to highlight the recent update on the consensus guidelines on anticoagulants in interventional radiology published in JVIR. These are excellent and comprehensive reviews to help guide practice relevant to all IR's. Davidson JC et al. (2019). Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part I: Review of Anticoagulation Agents and Clinical Considerations. Journal [...]

Apply for Membership Now!
Go to Top